⌘K
Loading ticker…
As of 2026-08-24, Sarepta Therapeutics,, Inc. Common Stock (SRPT) has a 3-month relative strength percentile of 63 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 50. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 5.1%, relative volume 0.46×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
SRPT is held by 34 ETFs as of May 2026. Top owner: SCHA at 0.04% weight, $9M notional. Top 3 carry $21M.
Held by 98 ETFs · $641M across latest filings · largest weight 5.87% (MNVT).
Top 10 by value, from SEC N-PORT-P filings dated May 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| SCHASchwab U.S. Small-Cap ETF | 0.04% | $9M | — |
| VIOOVanguard S&P Small-Cap 600 ETF | 0.11% | $6M | — |
| VHTVanguard Health Care ETF | 0.03% | $5M | — |
| RWJ | 0.13% | $2M | +0.01 pp |
| VONGVanguard Russell 1000 Growth ETF |
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| 0.00% |
| $2M |
| — |
| SBIO | 1.20% | $2M | +0.06 pp |
| AVSC | 0.06% | $2M | +0.03 pp |
| VIOVVanguard S&P Small-Cap 600 Value ETF | 0.09% | $2M | — |
| VIOGVanguard S&P Small-Cap 600 Growth ETF | 0.14% | $1M | — |
| PSCH | 1.00% | $1M | −0.05 pp |
Showing 10 of 34 ETF owners.
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | SRPT Jan avg: 1.97% median: -4.52% win: 25% σ: 14.33% n: 4 2022-04-12 → 2026-07-31 | SRPT Feb avg: -4.63% median: -4.20% win: 25% σ: 10.38% n: 4 2022-04-12 → 2026-07-31 | SRPT Mar avg: 0.92% median: 7.04% win: 75% σ: 29.84% n: 4 2022-04-12 → 2026-07-31 | SRPT Apr avg: -6.72% median: -4.04% win: 0% σ: 5.54% n: 5 2022-04-12 → 2026-07-31 | SRPT May avg: -10.05% median: 0.68% win: 60% σ: 17.95% n: 5 2022-04-12 → 2026-07-31 | SRPT Jun avg: -7.34% median: 0.56% win: 60% σ: 28.44% n: 5 2022-04-12 → 2026-07-31 | SRPT Jul avg: -2.52% median: -5.35% win: 20% σ: 15.71% n: 5 2022-04-12 → 2026-07-31 | SRPT Aug avg: 8.91% median: 11.24% win: 75% σ: 9.47% n: 4 2022-04-12 → 2026-07-31 (current) | SRPT Sep avg: -0.23% median: 0.62% win: 75% σ: 5.77% n: 4 2022-04-12 → 2026-07-31 | SRPT Oct avg: -3.96% median: 2.02% win: 75% σ: 29.04% n: 4 2022-04-12 → 2026-07-31 | SRPT Nov avg: 5.79% median: 6.77% win: 75% σ: 13.08% n: 4 2022-04-12 → 2026-07-31 | SRPT Dec avg: 4.05% median: 3.18% win: 75% σ: 11.41% n: 4 2022-04-12 → 2026-07-31 |